National drug utilisation patterns of antithrombotic and anti-inflammatory therapies: a cross-national comparison between Switzerland and Germany

Swiss Med Wkly. 2026 Nov. 16;156(11):5371.

Interessenskonflikte:

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. – CM has received research support from the Swiss National Science Foundation, the Swiss Heart Foundation, Innosuisse, University Hospital Basel, the University of Basel; Abbott, AstraZeneca, Beckman Coulter, Boehringer Ingelheim, BRAHMS Thermo Fisher Scientific, Idorsia, LSI Medience Corporation, Novartis, Ortho Diagnostics, Quidel, Roche, Siemens, Singulex, SpinChip, Sphingotec and Upstream all paid to the institution. He has also received speaker honoraria/consulting honoraria from Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, BMS, Daiichi Sankyo, Idorsia, Novartis, Novo Nordisk, Osler, Roche, SpinChip and Sanofi, again all paid to the institution. – CRM is supported by the Swiss National Science Foundation and by Innosuisse and has currently ongoing research collaborations with Eli Lilly, Novartis and IBSA, all unrelated to this topic. – FG has been supported by Deutsche Herzstiftung and has received speaker honoraria from AstraZeneca. – FM has been supported by Deutsche Forschungsgemeinschaft (SFB TRR219, Project-ID 322900939) and Deutsche Herzstiftung. Saarland University has received scientific support from Ablative Solutions, Medtronic and ReCor Medical. Until May 2024, FM has received speaker honoraria/consulting fees from Ablative Solutions, AstraZeneca, Inari, Medtronic, Merck, Novartis, Philips and ReCor Medical. – JB has been supported by an Edinburgh Doctoral College Scholarship and research grants from the University of Basel, University Hospital Basel, the Division of Internal Medicine, the Swiss Academy of Medical Sciences, the Gottfried and Julia Bangerter-Rhyner Foundation, the Swiss National Science Foundation, the Swiss Heart Foundation, and has received honoraria from Siemens, Roche Diagnostics, Ortho Clinical Diagnostics, Quidel Corporation and Beckman Coulter, and travel support from Medtronic and Vascularmedical, all outside the submitted work. – LL has received speaker honoraria and/or consulting fees from AstraZeneca, Medtronic, Pfizer, Recor, Servier and Sanofi, all paid to the institution. – MK has received consulting fees from Merck (Merck KGaA). – MS has received speaker honoraria or consulting fees from Apontis, AstraZeneca, BMS, CSL Vifor, Daiichi Sankyo, Novartis, Pfizer and TAD, all outside the submitted work. – UL has received speaker honoraria or consulting fees from Amgen, Boehringer Ingelheim, Daiichi Sankyo, Novartis and Sanofi, all outside the submitted work. – The other authors have nothing to declare.